| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 03/18/2004 | US20040053908 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 03/18/2004 | US20040053907 Cell adhesion inhibitors |
| 03/18/2004 | US20040053884 Comprises N-acylated hydroxyproline derivatives and glycosaminoglycans (chondroitin sulfate); for treatment of arthritis |
| 03/18/2004 | US20040053330 Amino polyols and amino sugars |
| 03/18/2004 | US20040053217 Using conjugate agents comprise of photoreactive moiety to identify preferential micro and/or macromolecules in heterologous mixtures |
| 03/18/2004 | US20040052981 Ink jet recording material |
| 03/18/2004 | CA2536010A1 Boronic acid salts useful in parenteral formulations for selective thrombin inhibition |
| 03/18/2004 | CA2535792A1 Boronic acid salts ant their use in the treatment of thrombosis |
| 03/18/2004 | CA2535788A1 Multivalent metal salts of boronic acids for treating thrombosis |
| 03/18/2004 | CA2499380A1 Novel vinyl carboxylic acid derivatives and their therapeutical use |
| 03/18/2004 | CA2497979A1 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 03/18/2004 | CA2495284A1 Diarylurea derivatives and their use as chloride channel blockers |
| 03/18/2004 | CA2491051A1 Atorvastatin calcium form vi or hydrates thereof |
| 03/17/2004 | EP1398166A1 Ink jet recording material and light-stabilising agent |
| 03/17/2004 | EP1398030A2 Dipeptidyl peptidase IV effectors |
| 03/17/2004 | EP1397340A2 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 03/17/2004 | EP1397339A1 (ethylene)-(propylene)-triaminepentaacetic acid derivatives, process for their production, and their use for the production of pharmaceutical agents |
| 03/17/2004 | EP1397128A1 Kappa opiate agonists for the treatment of bladder diseases |
| 03/17/2004 | EP1240140B1 Method for the production of n-alkenyl amides |
| 03/17/2004 | EP1144365B1 Inhibitors of alpha-4 beta-1 mediated cell adhesion |
| 03/17/2004 | EP1140820B1 New amidino derivatives and their use as thrombin inhibitors |
| 03/17/2004 | EP1140802B1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines |
| 03/17/2004 | EP0998488B1 Polyol-amino acid compounds having anti-helicobacter pylori activity |
| 03/17/2004 | EP0891362B1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 03/17/2004 | CN1483022A Crystalline forms of atorvastatin |
| 03/17/2004 | CN1142138C Preparation of thiol-carbamate and sulfocyanic ester compound |
| 03/16/2004 | US6706893 Methods of making pyrrolidones |
| 03/16/2004 | US6706891 Comprises conversion of oxalamide to dithiooxalamide, followed by conversion of the dithiooxalamide to either a 4,5-bisimino-(1,3)dithiolane or 2,3-bisimino-(1,4)dithiane |
| 03/16/2004 | US6706765 Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 03/16/2004 | US6706753 Integrin receptor inhibitors |
| 03/16/2004 | US6706745 Biphenylamidine derivatives |
| 03/16/2004 | US6706742 Alpha-amino-acid compounds |
| 03/16/2004 | US6706735 Nitrogen compounds such as n-(3-(4-benzyl-2-piperidinyl)propyl )-n'-(3-cyanophenyl)urea, used as chemotactic cytokine controllers administered for prophylaxis of asthma, allergies and autoimmune diseases |
| 03/11/2004 | WO2004020445A2 4-(3,3-dihalo-allyloxy) phenol derivatives having pesticidal properties |
| 03/11/2004 | WO2004020432A1 Arylamides |
| 03/11/2004 | WO2004020407A1 Benzenesulfonate of 4-fluoro-2-cyanopyrrolidine derivative |
| 03/11/2004 | WO2004020401A1 Synthesis of sulfonamide derivatives |
| 03/11/2004 | WO2003040337A3 Polyamide modulators of cox2 transcription |
| 03/11/2004 | WO2002076404A3 Fatty alcohol drug conjugates |
| 03/11/2004 | US20040049071 Contacting non-fluorous phase with fluorous phase at first phase interface; fluorous-tagged compound distributes between the phases; and contacting fluorous phase with second non-fluorous phase at a second phase interface. |
| 03/11/2004 | US20040049055 Oligo/polysuccinimides, process for producing thereof and their use |
| 03/11/2004 | US20040049049 Stereoselective synthesis of 1,2-disubstituted cycloalkyls |
| 03/11/2004 | US20040049046 Small molecule inhibitors of rotamase enzyme activity |
| 03/11/2004 | US20040049038 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease |
| 03/11/2004 | US20040049037 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 03/11/2004 | US20040049035 Pyrrolecarboxamides and pyrrolethioamides as fungicides |
| 03/11/2004 | US20040048913 Substituted biaryl amides as C5a receptor modulators |
| 03/11/2004 | US20040048897 Il-8 receptor antagonists |
| 03/11/2004 | US20040048858 Chalcone derivatives and their use to treat diseases |
| 03/11/2004 | US20040048856 Monoamine reuptake inhibitors for treatment of CNS disorders |
| 03/11/2004 | US20040048802 Hepatitis C virus inhibitors |
| 03/11/2004 | US20040048772 Preventives for arthritis |
| 03/11/2004 | US20040048346 Synthesis of chiral intermediates useful in preparing pharmacologically active compounds |
| 03/11/2004 | US20040047709 Locking nut, bolt and clip systems and assemblies |
| 03/11/2004 | DE10238865A1 New carboxamides are melanin-concentrating hormone receptor antagonists, useful for treating e.g. metabolic diseases, diabetes, eating disorders, cardiovascular disease, emotional disorders, reproductive and memory disorders |
| 03/10/2004 | EP1396486A1 Bis-paraphenylendiamine derivatives comprising pyrrolidine groups and their use for the colouration of keratinic fibres |
| 03/10/2004 | EP1396269A1 Boronic acid salts of multivalent metals used in the preparation of a medicament for treating thrombosis |
| 03/10/2004 | EP1395606A1 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 03/10/2004 | EP1395571A1 Compounds and methods for the treatment or prevention of flavivirus infections |
| 03/10/2004 | EP1395561A1 Carbamate and oxamide compounds as inhibitors of cytokine production |
| 03/10/2004 | EP1395553A1 Pyrrolidine derivatives as factor xa inhibitors |
| 03/10/2004 | EP1395551A2 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases |
| 03/10/2004 | EP1395534A1 Impurity inhibition in olefin metathesis reactions |
| 03/10/2004 | EP1395256A2 Prodrugs via acylation with cinnamate |
| 03/10/2004 | EP1395242A1 Liquid pharmaceutical composition |
| 03/10/2004 | CN1481358A Carboxylic acid amide derivatives and their use in treatment of thromboembolic diseases and tumours |
| 03/10/2004 | CN1480453A Compound of fluorene class containing dual hetero atoms as well as its synthetic method and application |
| 03/09/2004 | US6703512 Intermediates for the production of quinolone carboxylic acid derivatives |
| 03/09/2004 | US6703511 Method for obtaining pure n-vinyl pyrrolidone |
| 03/09/2004 | US6703426 Treatment of breast cancer |
| 03/09/2004 | US6703420 Amino-thio-acrylonitriles as MEK inhibitors |
| 03/09/2004 | US6703379 Benzene derivatives and pharmaceutical use thereof |
| 03/09/2004 | US6703368 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
| 03/09/2004 | US6703042 Salts of L-carnitine and lower alkanoyl L-carnitine |
| 03/09/2004 | US6702705 Prodrugs activated by targeted catalytic proteins |
| 03/04/2004 | WO2004018644A2 HETEROGENEOUS FOLDAMERS CONTAINING α, β, AND/OR Ϝ-AMINO ACIDS |
| 03/04/2004 | WO2004018446A1 Process for the production of ϝ-keto acetals |
| 03/04/2004 | WO2004018436A2 Compounds derived from aryl carbamates, preparation thereof and uses of same |
| 03/04/2004 | WO2004018426A1 Organic acid salt of amlodipine |
| 03/04/2004 | WO2004018414A2 Antibacterial agents |
| 03/04/2004 | WO2004018410A1 Substituted benzanilide compound and pest control agent |
| 03/04/2004 | WO2003106456A3 Azabicyclo-octane and nonane derivatives with ddp-iv inhibiting activity |
| 03/04/2004 | WO2003105756A3 Stereoselective synthesis of 1,2-disubstituted cycloalkyls |
| 03/04/2004 | WO2003101391A3 Therapeutic methods |
| 03/04/2004 | WO2003070755A3 Compounds, compositions and method for transporting cyclosporin molecules through the blood brain barrier |
| 03/04/2004 | WO2003024928A3 Novel aminoazetidine, -pyrrolidine and -piperidine derivatives |
| 03/04/2004 | US20040044202 Functionalized monomers for synthesis of rubbery polymers |
| 03/04/2004 | US20040044081 Hypotensive agents; cardiovascular disorders; anticholesterol agents; antiarrhythmia agents |
| 03/04/2004 | US20040044049 Compounds for inhibiting insulin secretion and methods related thereto |
| 03/04/2004 | US20040044037 Sleep disorders; antidepressants; analgesics; central nervous system disorders |
| 03/04/2004 | US20040044008 Dietetics; antilipemic agents; non-insulin dependent diabetes; cardiovascular disorders |
| 03/04/2004 | US20040043920 Chelate compound of metal and dithiocarbamate; therapy, diagnosis |
| 03/04/2004 | US20040043426 Using "tethering" where potential ligands are covalently bonded or "tethered" to a target and subsequently identified |
| 03/04/2004 | DE10238742A1 New N-(maleimidyl- or thiohydantoinyl-alkyl)-piperazine derivatives, are androgen receptor destabilizers and/or inhibitors useful e.g. for treating prostate carcinoma or hyperplasia |
| 03/03/2004 | EP1394152A1 2-iminoimidazole derivatives (1) |
| 03/03/2004 | EP1392706A1 Olefin polymerization catalysts containing a pyrrole bisimine ligand |
| 03/03/2004 | EP1392682A2 Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 03/03/2004 | EP1392656A2 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors |
| 03/03/2004 | EP1392651A1 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists |
| 03/03/2004 | EP1392643A2 Trisubstituted-n- (1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors |